Literature DB >> 209581

Isoproterenol and propranolol: ability to cross the blood-brain barrier and effects on cerebral circulation in man.

J Olesen, K Hougård, M Hertz.   

Abstract

Using the "double indicator" technique the ability of 3H-isoproterenol and 14C-propranolol to cross the blood-brain barrier was studied in man. In 3 subjects extraction of isoproterenol was 3.8% in a single passage and the PS product was 2.0 ml/100g/min. In 4 patients extraction of propranolol was 63% and PS was 46.7 ml/100/min. Regional cerebral blood flow (rCBF) was studied in man with the 133Xe-intraarterial injection method. Intracarotid isoproterenol (3 migrogram/min., 6 patients) caused a significant reduction in rCBF, but after correction for a concomitant decrease in arterial PCO2 the alteration was no longer significant (59.8 -51.7/57.4 ml/100g/min.). Intracarotid propranolol (0.15 mg/kg, 11 patients) caused no significant change in rCBF, but after correction for arterial PCO2 change the lateration although on 4% was just significant, p less than 0.05. (56.3 -55.8/54.1 ml/100g/min). After propranolol the rCBF changes caused by alterations in the arterial PCO2 were normal and the focal flow increase during hand work could not be changed by simultaneous intracarotid propranolol.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 209581     DOI: 10.1161/01.str.9.4.344

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  17 in total

1.  How the heart speaks to the brain: neural activity during cardiorespiratory interoceptive stimulation.

Authors:  Mahlega S Hassanpour; Lirong Yan; Danny J J Wang; Rachel C Lapidus; Armen C Arevian; W Kyle Simmons; Jamie D Feusner; Sahib S Khalsa
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-10-10       Impact factor: 6.237

2.  The impact of acute and chronic catecholamines on respiratory responses to hypoxic stress in the rat.

Authors:  David Hauton; Andrew Holmes; Oliver Ziff; Prem Kumar
Journal:  Pflugers Arch       Date:  2013-01-06       Impact factor: 3.657

3.  Effect of acute and prolonged treatment with propranolol on cerebral blood flow and cerebral oxygen metabolism in healthy volunteers.

Authors:  P L Madsen; S Vorstrup; J F Schmidt; O B Paulson
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

4.  Bolus isoproterenol infusions provide a reliable method for assessing interoceptive awareness.

Authors:  S S Khalsa; D Rudrauf; C Sandesara; B Olshansky; D Tranel
Journal:  Int J Psychophysiol       Date:  2008-09-27       Impact factor: 2.997

5.  Familial and sporadic hemiplegic migraine: diagnosis and treatment.

Authors:  Nadine Pelzer; Anine H Stam; Joost Haan; Michel D Ferrari; Gisela M Terwindt
Journal:  Curr Treat Options Neurol       Date:  2013-02       Impact factor: 3.598

6.  Non-selective beta-adrenergic blockade prevents reduction of the cerebral metabolic ratio during exhaustive exercise in humans.

Authors:  Thomas Seifert Larsen; Peter Rasmussen; Morten Overgaard; Niels H Secher; Henning B Nielsen
Journal:  J Physiol       Date:  2008-04-10       Impact factor: 5.182

7.  Cardiorespiratory noise correction improves the ASL signal.

Authors:  Mahlega S Hassanpour; Qingfei Luo; W Kyle Simmons; Justin S Feinstein; Martin P Paulus; Wen-Ming Luh; Jerzy Bodurka; Sahib S Khalsa
Journal:  Hum Brain Mapp       Date:  2018-02-15       Impact factor: 5.038

8.  Transport of propranolol and lidocaine through the rat blood-brain barrier. Primary role of globulin-bound drug.

Authors:  W M Pardridge; R Sakiyama; G Fierer
Journal:  J Clin Invest       Date:  1983-04       Impact factor: 14.808

9.  Interleukin-6 amplifies glucagon secretion: coordinated control via the brain and pancreas.

Authors:  Tammy M Barnes; Yolanda F Otero; Amicia D Elliott; Alicia D Locke; Carlo M Malabanan; Anastasia G Coldren; Marcela Brissova; David W Piston; Owen P McGuinness
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-09-09       Impact factor: 4.310

10.  Adrenergic and glucocorticoid receptor antagonists reduce ozone-induced lung injury and inflammation.

Authors:  Andres R Henriquez; Samantha J Snow; Mette C Schladweiler; Colette N Miller; Janice A Dye; Allen D Ledbetter; Judy E Richards; Kevin Mauge-Lewis; Marie A McGee; Urmila P Kodavanti
Journal:  Toxicol Appl Pharmacol       Date:  2017-12-13       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.